37 Amendments of Tiemo WÖLKEN related to 2018/0225(COD)
Amendment 54 #
Proposal for a decision
Recital 5
Recital 5
(5) RAcknowledging climate change as one of the biggest and most important global and societal challenges and reflecting the importance of tackling climate change in line with the Union's commitments to implement the Paris Agreement and the United Nations Sustainable Development Goals, this Specific Programme will contribute to mainstream climate actions and to the achievement of an overall target of 2530 % of the EU budget expenditures supporting climate objectives. Actions under this Specific Programme are expected to contribute 35% of the overall financial envelope of the Specific Programme to climate objectives. Relevant actions will be identified during the Specific Programme's preparation and implementation, and reassessed in the context of the relevant evaluations and review processes.
Amendment 66 #
Proposal for a decision
Article 2 – paragraph 2 – point f
Article 2 – paragraph 2 – point f
(f) fostering open science and ensuring visibility to the public and open access to research data and results;
Amendment 68 #
Proposal for a decision
Article 2 – paragraph 2 – point h a (new)
Article 2 – paragraph 2 – point h a (new)
(ha) supporting implementation of UN Sustainable Development Goals
Amendment 69 #
Proposal for a decision
Article 2 – paragraph 2 – point i
Article 2 – paragraph 2 – point i
(i) reinforcing the link between research and innovation and other policies, including particular Sustainable Development Goals;
Amendment 71 #
Proposal for a decision
Article 2 – paragraph 2 – point m a (new)
Article 2 – paragraph 2 – point m a (new)
(ma) accelerating the transition towards a green, sustainable and decarbonised European industry and society;
Amendment 82 #
Proposal for a decision
Article 4 – paragraph 1
Article 4 – paragraph 1
1. In accordance with Article 9(1)of Regulation … FP/RfP Regulation, the financial envelope for the implementation of the Specific Programme for the period 2021 to 2027 shall be EUR 94 1120 000 000 000 in constant prices [EUR 135 248 000 000 in current prices].
Amendment 89 #
Proposal for a decision
Article 10 – paragraph 4 – subparagraph 1
Article 10 – paragraph 4 – subparagraph 1
The EIC Board shall have a President who shall be appointed by the Commission following a transparent recruitment process. The President shall be a high profile public figure linked to the research and innovation world.
Amendment 90 #
Proposal for a decision
Article 10 – paragraph 4 – subparagraph 3
Article 10 – paragraph 4 – subparagraph 3
The President shall chair the EIC Board, prepare its meetings, assign tasks to members, and may establish dedicated sub- groups, in particular to identify emerging technology trends from EIC's portfolio. He or she shall promote the EIC, act as interlocutor with the Commission and represent the EIC in the world of research and innovation. The Commission may provide for administrative support for the President to undertake his or her duties.
Amendment 116 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 2 a (new)
Annex I – part II – point 1 – point 1.1 – paragraph 2 a (new)
Health research provides the knowledge basis for more healthy people and for better patient care. Health research has unique features, connecting and interacting closely with innovation, patient care and population health, and operating in a multidisciplinary environment with complex regulations. Health research delivers societal value beyond financial return and is primary concern of European citizens.
Amendment 118 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 3
Annex I – part II – point 1 – point 1.1 – paragraph 3
Health research and innovation research and innovation have played a significant part in this achievement but also in improving productivity and quality in the health and care industry. However, the EU continues to face novel, newly emerging or persisting challenges that are threatening its citizens and public health, the sustainability of its health care and social protection systems, as well as the competitiveness of its health and care industry. Major health challenges in the EU include: the lack of effective health promotion and disease prevention; the rise of non-communicable diseases; the spread of antimicrobial drug resistance and the emergence of infectious epidemics; increased environmental pollution; the persistence of health inequalities among and within countries affecting disproportionally people that are disadvantaged or in vulnerable stages of life; the detection, understanding, control, prevention and mitigation of health risks in a rapidly changing social, urban and natural environment; the increasing costs for European health care systems and the progressive introduction of personalised medicine approaches and digitalisation in health and care; and the increasing pressure on the European health and care industry to remain competitive in and by developing health innovation vis-a-vis new and emerging global players; and the increased interdependence of the Union on other regions as a consequence of globalisation calling for a global health approach.
Amendment 123 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 4
Annex I – part II – point 1 – point 1.1 – paragraph 4
These health challenges are complex, interlinked and global in nature and require multidisciplinary, cross-sectorial and transnational collaborations. Research and innovation activities will build close linkages between discovery, clinical, epidemiological, environmental and socio- economic research as well as with regulatory sciences. They will harness the combined skills of academia and industry and foster their collaboration with health services, patients, policy-makers, civil society organisations and citizens in order to leverage on public funding and ensure the uptake of results in clinical practice as well as in health care systems. They will foster strategic collaboration at EU and international level in order to pool the expertise, capacities and resources needed to create economies of scale, scope and speed as well as to share the expected benefits and financial risks involved.
Amendment 126 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 7
Annex I – part II – point 1 – point 1.1 – paragraph 7
Activities will contribute directly to the following Sustainable Development Goal (SDGs) in particular: SDG 2 - Zero Hunger. SDG 3 – Good Health and Well- Being for People; SDG13 – Climate Action.
Amendment 130 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 2
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 2
– Maternal, paternal, infant and child health as well as the role of parents and child and maternal survival;
Amendment 132 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 6 a (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 6 a (new)
– Paediatric diseases; – Diseases related to women. Gender and health.
Amendment 134 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 1
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 1
Improved understanding of health drivers and risk factors determined by the social, economic and physical environment in people’s everyday life and at the workplace, including the health impact of digitalisation, pollution, rapid urbanization, climate change and other national and transnational environmental issues, will contribute to identify and mitigate health risks and threats; to reducing death and illness from exposure to chemicals and environmental pollution; to supporting environmental-friendly, healthy, resilient and sustainable living and working environments; to promoting healthy lifestyles and consumption behaviour; and to developing an equitable, inclusive and trusted society.
Amendment 138 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 2 – indent 2
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 2 – indent 2
– Environmental, occupational, economic, political, social and behavioural factors impacting physical and mental health and well-being of people and their interaction, with special attention to vulnerable and disadvantaged people;
Amendment 144 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.3 – paragraph 2 – indent 7 a (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.3 – paragraph 2 – indent 7 a (new)
- Infrastructure and capabilities to harness the potential of genomic medicine advances into standard clinical practice.
Amendment 147 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – indent 1
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – indent 1
– Drivers for the emergence or re- emergence of infectious diseases and their spread, including transmission mechanisms from animals to humans (zoonosis), or from other parts of the environment (water, soil, plants, food) to humans and the implementation of empirical preventative solutions that minimize transmission;
Amendment 148 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – indent 2 a (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – indent 2 a (new)
- Development of new antibiotics to combat superbacteria;
Amendment 153 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – indent 6
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – indent 6
– Trans-border aspects of infectious diseases and specific challenges in low- and middle-income countries (LMICs), such as tropical diseasesin particular poverty-related diseases, such as neglected tropical diseases, AIDS, tuberculosis and malaria.
Amendment 155 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.5 – paragraph 1
Annex I – part II – point 1 – point 1.2 – point 1.2.5 – paragraph 1
Health technologies and tools are vital for public health and contributed to a large extent to the important improvements achieved in the quality of life, health and care of people, in the EU. It is thus a key strategic challenge to design, develop, deliver and implement suitable, affordable, trustable, safe, and cost-effective tools and technologies for health and care, taking due account of the needs of people with disabilities and the aging society. These include artificial intelligence and other digital tools and technologies, offering significant improvements over existing ones, as well as stimulating a competitive and sustainable health-related industry that creates high-value jobs. The European health-related industry is one of the critical economic sectors in the EU, accounting for 3% of GDP and 1.5 million employees.
Amendment 157 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.5 – paragraph 2 – indent 5
Annex I – part II – point 1 – point 1.2 – point 1.2.5 – paragraph 2 – indent 5
– The safety, efficacy and quality of tools and technologies for health and care as well as their ethical legal and social impact, their cost-effectiveness and affordability;
Amendment 162 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.6 – paragraph 1
Annex I – part II – point 1 – point 1.2 – point 1.2.6 – paragraph 1
Health systems are a key asset of the EU social systems, accounting for 24 million employees in the health and social work sector in 2017. It is a main priority to render health systems accessible, affordable, cost- effective, resilient, sustainable and trusted as well as to reduce inequalities, including by unleashing the potential of data-driven and digital innovation for better health and person- centred care building on open European data infrastructures. This will advance the digital transformation of health and care.
Amendment 174 #
European citizens, state institutions and the economy need to be protected from the continued threats of organised crime, including firearms trafficking, drug trafficking and trafficking in human beings. Strengthening protection and security through better border management is also key. Cybercrime is on the increase and related risks are diversifying as the economy and society digitalise. Europe needs to continue its effots to improve cybersecurity, digital privacy, personal data protection and actively combat the spread of false and harmful information in order to safeguard democratic and economic stability. Lastly, further efforts are required to limit the effects on lives and livelihoods of extreme weather events which are intensifying due to climate change, such as floods, storms or droughts leading to forest fires, land degradation and other natural disasters, e.g. earthquakes. Disasters, whether natural or man-made, can put at risk important societal functions, such as health, energy supply and government.
Amendment 192 #
Proposal for a decision
Annex I – part II – point 4 – point 4.1 – paragraph 11
Annex I – part II – point 4 – point 4.1 – paragraph 11
Activities will contribute directly to the following Sustainable Development Goals (SDGs) in particular: SDG 3 - Good Health and Well Being, SDG 7 - Affordable and Clean Energy; SDG 9 - Industry, Innovation and Infrastructure; SDG 11 - Sustainable Cities and Communities; SDG 13 - Climate Action.
Amendment 201 #
Activities will contribute directly to the following Sustainable Development Goals (SDGs) in particular: SDG 2 – Zero Hunger; SDG 3 - Good Health and Well- Being, SDG 6 - Clean Water and Sanitation; SDG 11 – Sustainable Cities and Communities; SDG 12 - Responsible Consumption and Production; SDG 13 – Climate Action; SDG 14 – Life Below Water; SDG 15 - Life on Land.
Amendment 208 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.3 – paragraph 2 – indent 1
Annex I – part II – point 5 – point 5.2 – point 5.2.3 – paragraph 2 – indent 1
– Methods, technologies and innovative tools for sustainable and resilient production in farming and forestry and for the most efficient use of water resources;
Amendment 209 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.3 – paragraph 2 – indent 4 a (new)
Annex I – part II – point 5 – point 5.2 – point 5.2.3 – paragraph 2 – indent 4 a (new)
– Open data systems that foster sharing of plant, pathogen and environmental data and knowledge that enable further scientific research, environmental planning and development of commercial products;
Amendment 210 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.3 – paragraph 2 – indent 7
Annex I – part II – point 5 – point 5.2 – point 5.2.3 – paragraph 2 – indent 7
– AInnovative agricultural and forestry systems from farm to landscape levels; the use and delivery of ecosystem services in primary production;
Amendment 212 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.4 – introductory part
Annex I – part II – point 5 – point 5.2 – point 5.2.4 – introductory part
5.2.4. Sea and, Oceans and Blue Economy
Amendment 213 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.4 – paragraph 2 – indent 1 a (new)
Annex I – part II – point 5 – point 5.2 – point 5.2.4 – paragraph 2 – indent 1 a (new)
– Marine living resources, the fishing technologies, aquaculture, and processing and marketing technologies; – Developing new bio products based on marine organisms, with a wide range of applications opening new products and services opportunities;
Amendment 217 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.5 – paragraph 1
Annex I – part II – point 5 – point 5.2 – point 5.2.5 – paragraph 1
The combined effects of population growth, resource scarcity and overexploitation, environmental degradation, climate change and migration create unprecedented challenges which require food system transformation (FOOD 2030).20 Current food production and consumption are largely unsustainable while we are confronted with the double burden of malnutrition, characterised by the coexistence of undernutrition and obesity. Future food systems need to deliver sufficient safe, healthy, affordable and quality food for all, underpinned by resource efficiency, sustainability (including the reduction of GHG emissions, pollution and waste production), linking land and sea, reducing food waste, enhancing food production from the seas and oceans and encompassing the entire 'food value chain' from producers to consumers – and back again. This needs to go hand in hand with development of the food safety system of the future and the design, development and delivery of tools, technologies and digital solutions that provide significant benefits for producers and consumers and improve the competitiveness and sustainability of the food value chain. Furthermore, there is a need to foster behavioural changes in food consumption and production patterns towards nutritious and healthy diets as well as to engage primary producers, industry (including SMEs), retailers, food service sectors, consumers, and public services. _________________ 20 SWD(2016) 319 final: European Research and Innovation for Food and Nutrition Security
Amendment 219 #
Proposal for a decision
Annex I – part II – point 5 – point 5.2 – point 5.2.6 – paragraph 1
Annex I – part II – point 5 – point 5.2 – point 5.2.6 – paragraph 1
Bio-based innovation lays the foundations for the transition away from a fossil-based economy by encompassing the sustainable sourcing, industrial processing and conversion of biomass from land and sea into bio-based materials and products. It also capitalises on the potential of living resources, life sciences, green and industrial biotechnology for new discoveries, products and processes. Bio- based innovation, including technologies, can bring new economic activities and employment to regions and cities, contribute to revitalising rural and coastal economies and strengthen the circularity of the bioeconomy.
Amendment 220 #
Proposal for a decision
Annex I – part II – point 6 – point 6.1 – paragraph 3
Annex I – part II – point 6 – point 6.1 – paragraph 3
The JRC performs its own independent research and is a strategic manager of knowledge, information, data and competences to deliver high quality and relevant evidence for smarter policies. To achieve this, the JRC works together with the best organisations world-wide, and with international, national and regional stakeholders. Its research contributes to the general objectives and priorities of Horizon Europe and is focussed on European policy priorities, supporting a Europe that is safe and secure, prosperous and sustainable, social and stronger on the global scene.
Amendment 222 #
Proposal for a decision
Annex I – part III – point 1 – point 1.1 – paragraph 3 – indent 1
Annex I – part III – point 1 – point 1.1 – paragraph 3 – indent 1
– Focus on breakthrough and disruptive innovations, including social, that have the potential to create new markets or enable new solutions, as opposed to those which make incremental improvements in existing products, services or business models;
Amendment 223 #
Proposal for a decision
Annex I – part III – point 1 – point 1.1 – paragraph 3 – indent 3
Annex I – part III – point 1 – point 1.1 – paragraph 3 – indent 3
– Research and Innovations that cut across different scientific, technological (e.g. combining physical and digital) fields and sectors will be encouraged;
Amendment 224 #
Proposal for a decision
Annex I – part III – point 1 – point 1.1 – point 1.1.1 – paragraph 2
Annex I – part III – point 1 – point 1.1 – point 1.1.1 – paragraph 2
The Pathfinder overall objective will be to nurture potential market creating innovation out of breakthrough scientific and technological ideas, and bring them to demonstration stage or development of business cases or strategies for further take-up by the Accelerator or any other market deployment solution. To that end, the Pathfinder will initially support the earliest stages of scientific and technological research and development, including proof of concept and prototypes for technology validation.